350 related articles for article (PubMed ID: 18086494)
1. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
[TBL] [Abstract][Full Text] [Related]
2. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency.
Bhattacharya A; Slatter MA; Chapman CE; Barge D; Jackson A; Flood TJ; Abinun M; Cant AJ; Gennery AR
Bone Marrow Transplant; 2005 Aug; 36(4):295-9. PubMed ID: 15968287
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
5. Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID.
Tjønnfjord GE; Steen R; Veiby OP; Friedrich W; Egeland T
Blood; 1994 Nov; 84(10):3584-9. PubMed ID: 7524743
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
Knutsen AP; Wall DA
J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
[TBL] [Abstract][Full Text] [Related]
8. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
[TBL] [Abstract][Full Text] [Related]
10. Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
Williams RJ; Clarke E; Blair A; Evely R; Hale G; Waldmann H; Brookes S; Pamphilon DH
Cytotherapy; 2000; 2(1):5-14. PubMed ID: 12042050
[TBL] [Abstract][Full Text] [Related]
11. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
[TBL] [Abstract][Full Text] [Related]
12. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.
Scarselli A; Di Cesare S; Capponi C; Cascioli S; Romiti ML; Di Matteo G; Simonetti A; Palma P; Finocchi A; Lucarelli B; Pinto RM; Rana I; Palumbo G; Caniglia M; Rossi P; Carsetti R; Cancrini C; Aiuti A
J Clin Immunol; 2015 May; 35(4):373-83. PubMed ID: 25875698
[TBL] [Abstract][Full Text] [Related]
14. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
15. Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation.
Meyer RG; Wagner EM; Konur A; Bender K; Schmitt T; Hemmerling J; Wehler D; Hartwig UF; Roosnek E; Huber C; Kolbe K; Herr W
Bone Marrow Transplant; 2010 Apr; 45(4):668-74. PubMed ID: 19684624
[TBL] [Abstract][Full Text] [Related]
16. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
[TBL] [Abstract][Full Text] [Related]
17. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
[TBL] [Abstract][Full Text] [Related]
18. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
[TBL] [Abstract][Full Text] [Related]
19. Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.
Lim CK; Sun L; Feng Q; Law P; Chua WT; Lim SN; Hwang WY
J Hematol Oncol; 2008 Oct; 1():19. PubMed ID: 18947412
[TBL] [Abstract][Full Text] [Related]
20. Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency.
Slatter MA; Bhattacharya A; Abinun M; Flood TJ; Cant AJ; Gennery AR
Bone Marrow Transplant; 2005 Apr; 35(7):683-9. PubMed ID: 15723084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
